Stay updated on Venetoclax and Novel Agents in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.3.3. The entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:48:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:37:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. This change does not affect study record content or user interaction.
    Difference
    0.5%
    Check dated 2025-11-18T06:54:34.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Only layout tweaks and timestamp updates were observed; no substantive study information changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T20:55:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added new study status entries (2025-10-10, 2025-10-08, 2025-10-01) and current date; removed an earlier entry (2025-04-11). Overall, this updates status tracking rather than altering core content.
    Difference
    1%
    Check dated 2025-10-13T07:36:27.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    11%
    Check dated 2025-10-06T05:13:03.000Z thumbnail image

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.